Grove Bank & Trust’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.31K | Hold |
200
| – | – | ﹤0.01% | 713 |
|
|
2025
Q1 | $3.32K | Hold |
200
| – | – | ﹤0.01% | 724 |
|
|
2024
Q4 | $3.67K | Hold |
200
| – | – | ﹤0.01% | 628 |
|
|
2024
Q3 | $3.08K | Hold |
200
| – | – | ﹤0.01% | 614 |
|
|
2024
Q2 | $3.25K | Hold |
200
| – | – | ﹤0.01% | 532 |
|
|
2024
Q1 | $3.7K | Hold |
200
| – | – | ﹤0.01% | 542 |
|
|
2023
Q4 | $6.26K | Hold |
200
| – | – | ﹤0.01% | 517 |
|
|
2023
Q3 | $4.17K | Hold |
200
| – | – | ﹤0.01% | 589 |
|
|
2023
Q2 | $4.79K | Hold |
200
| – | – | ﹤0.01% | 549 |
|
|
2023
Q1 | $3.76K | Hold |
200
| – | – | ﹤0.01% | 590 |
|
|
2022
Q4 | $3K | Buy |
+200
| New | +$3K | ﹤0.01% | 554 |
|